Functional impact of cancer-associated mutations in the tumor suppressor protein ING4

Carcinogenesis

Volumn 31, Issue 11, 2010, Pages 1932-1938

  Moreno, Alberto ^a   Palacios, Alicia ^b   Orgaz, Jose Luis ^a   Jimenez, Benilde ^a   Blanco, Francisco J ^b,c   Palmero, Ignacio ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b CIC BIOGUNE   (Spain)

^c BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; INHIBITOR OF GROWTH 4 PROTEIN; MUTANT PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CANCER GENETICS; CELL DEATH; CELL GROWTH; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; GENE MUTATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL CYCLE PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MICE; MUTAGENESIS, SITE-DIRECTED; MUTATION; NIH 3T3 CELLS; PROTEIN CONFORMATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOMA; SUBCELLULAR FRACTIONS; TUMOR SUPPRESSOR PROTEINS;

EID: 78149267894     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq171     Document Type: Article

References (42)

1. Hahn, W.C. et al. (2002) Modelling the molecular circuitry of cancer. Nat. Rev. Cancer, 2, 331-341.
2. Hanahan, D. et al. (2000) The hallmarks of cancer. Cell, 100, 57-70.
3. Coles, A.H. et al. (2009) The ING gene family in the regulation of cell growth and tumorigenesis. J. Cell. Physiol., 218, 45-57.
4. 2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells. FEBS Lett., 570, 7-12.
5. Kim, S. et al. (2004) A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc. Natl Acad. Sci. USA, 101, 16251-16256.
6. Colla, S. et al. (2007) The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis. Blood, 110, 4464-4475.
7. Garkavtsev, I. et al. (2004) The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature, 428, 328-332.
8. Li, X. et al. (2008) ING4 induces cell growth inhibition in human lung adenocarcinoma A549 cells by means of Wnt-1/B-catenin signaling pathway. Anat. Rec., 291, 593-600.
9. Shen, J.C. et al. (2007) Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1. Cancer Res., 67, 2552-2558.
10. Ozer, A. et al. (2005) Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4. Cell Cycle, 4, 1153-1156.
11. Ozer, A. et al. (2005) The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc. Natl Acad. Sci. USA, 102, 7481-7486.
12. Hung, T. et al. (2009) ING4 mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate cellular transformation. Mol. Cell, 33, 248-256.
13. Palacios, A. et al. (2008) Molecular basis of histone H3K4me3 recognition by ING4. J. Biol. Chem., 283, 15956-15964.
14. Pena, P.V. et al. (2006) Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature, 442, 100-103.
15. Shi, X. et al. (2006) ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature, 442, 96-99.
16. Doyon, Y. et al. (2006) ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol. Cell, 21, 51-64.
17. Nozell, S. et al. (2008) The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes. Mol. Cell. Biol., 28, 6632-6645.
18. Iizuka, M. et al. (2008) Hbo1 Links p53-dependent stress signaling to DNA replication licensing. Mol. Cell. Biol., 28, 140-153.
19. Shiseki, M. et al. (2003) p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res., 63, 2373-2378.
20. Zhang, X. (2005) Nuclear localization signal of ING4 plays a key role in its binding to p53. Biochem. Biophys. Res. Commun., 331, 1032-1038.
21. Gunduz, M. et al. (2005) Frequent deletion and down-regulation of ING4, a candidate tumor suppresor gene at 12p13, in head and neck squamous cell carcinomas. Gene, 356, 109-117.
22. Raho, G. et al. (2007) Detection of novel mRNA splice variants of human ING4 tumor suppressor gene. Oncogene, 26, 5247-5257.
23. Li, M. et al. (2009) Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma. J. Pathol., 219, 87-95.
24. Unoki, M. et al. (2006) Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility. J. Biol. Chem., 281, 34677-34686.
25. Palmero, I. et al. (2001) Induction of senescence by oncogenic Ras. Methods Enzymol., 333, 247-256.
26. Goeman, F. et al. (2005) Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras. Mol. Cell. Biol., 25, 422-431.
27. Palmero, I. et al. (2002) Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2. Oncogene, 21, 2939-2947.
28. Gonzalez, L. et al. (2006) A functional link between the tumour suppressors ARF and p33ING1. Oncogene, 25, 5173-5179.
29. Kim, S. (2005) HuntING4 new tumor suppressors. Cell Cycle, 4, 516-517.
30. Li, J. et al. (2008) Role of ING4 in human melanoma cell migration, invasion, and patient survival. Carcinogenesis, 29, 1373-1379.
31. Xie, Y. et al. (2008) Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis. Cancer Lett., 271, 105-116.
32. Palacios, A. et al. (2006) Solution structure and NMR characterization of the binding to methylated histone tails of the plant homeodomain finger of the tumour suppressor ING4. FEBS Lett., 580, 6903-6908.
33. Gozani, O. et al. (2003) The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell, 114, 99-111.
34. Tsai, K. et al. (2008) Two wobble splicing events affect ING4 protein subnuclear localization and degradation. Exp. Cell Res., 314, 3130-3141.
35. Pena, P.V. et al. (2008) Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor. J. Mol. Biol., 380, 303-312.
36. Garate, M. et al. (2007) Phosphorylation of the tumor suppressor p33(ING1b) at Ser-126 influences its protein stability and proliferation of melanoma cells. FASEB J., 21, 3705-3716.
37. Campos, E.I. et al. (2004) Mutations of the ING1 tumor suppressor gene detected in human melanoma abrogate nucleotide excision repair. Int. J. Oncol., 25, 73-80.
38. Chen, G. et al. (2010) The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system. Oncogene, 29, 1498-1508.
39. Nie, J. et al. (2010) HECT ubiquitin ligase Smurf1 targets the tumor suppressor ING2 for ubiquitination and degradation. FEBS Lett., 584, 3005-3012.
40. Cai, L. et al. (2009) Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14. Melanoma Res., 19, 1-7.
41. Fang, F. et al. (2009) Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma. Cancer Epidemiol. Biomarkers Prev., 18, 409-416.
42. Kim, S. et al. (2010) A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis. Cancer Res., 70, 5155-5162.